NCT02180867 · OUTCOME

Mean Pharmacokinetic Parameters of Doxorubicin and Pazopanib

Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery · Source last updated 2026-06-17

This outcome was registered, but no numerical results were posted in the captured record.

Measure: Not reported
Unit: Not reported
Interval / dispersion: Not reported
Time frame: Up to 48 hours after the end of infusion

What was measured

Pharmacokinetic parameters such as the clearance of doxorubicin and pazopanib will be estimated.

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields

denom Units Selected: Participants
description: Pharmacokinetic parameters such as the clearance of doxorubicin and pazopanib will be estimated.
reporting Status: NOT_POSTED
time Frame: Up to 48 hours after the end of infusion
title: Mean Pharmacokinetic Parameters of Doxorubicin and Pazopanib
type: OTHER_PRE_SPECIFIED

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice